Health

Results: 1369-1380 of 9197

PR Newswire associated0

Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences

Compass Pathways Launches Proposed $150.0 Million Public Offering

UK Anti-Doping (UKAD

New ‘WhistleBot’ Joins the Fight Against Doping in Sport

Molecular Instruments Announces Fully Ambient-Temperature HCR™ Pro RNA-ISH on the BOND-III, Setting a New Standard for Clinical Automation

A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns

Michael Clay, Caidya's Chief Operating Officer

Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development

ViiV Healthcare showcases long-acting HIV innovation and potential of ultra long-acting pipeline, including new data for first third-generation integrase inhibitor at CROI 2026

Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample

Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services

Haleon responds to latest OHID data: 11% rise in child tooth decay extractions

Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

BeOne Medicines to Present at Upcoming Investor Conferences